Citable company snapshot

AMGN financial facts from SEC filings

Server-rendered

AMGEN INC's latest SEC-sourced 2026-03-31 period shows $8.62B in revenue and $1.82B in net income.

AMGN financial facts from SEC filings
MetricLatest periodLatest valuePrior valueYoY
xbrl:RevenueFromContractWithCustomerExcludingAssessedTaxMar 31, 2026$8.62B$9.87B-12.6%
xbrl:GrossProfitDec 31, 2020$4.74B$4.54B+4.3%
xbrl:OperatingIncomeLossMar 31, 2026$2.67B$2.72B-2.0%
xbrl:NetIncomeLossMar 31, 2026$1.82B$1.33B+36.5%
xbrl:NetCashProvidedByUsedInOperatingActivitiesMar 31, 2026$2.19B$1.60B+36.6%
Free Cash Flow (computed)Mar 31, 2026$1.48B$961.00M+53.7%

Source: SEC EDGAR XBRL; period Mar 31, 2026; filed May 1, 2026; accession 0000318154-26-000057.

Continue research

Follow same-sector companies and source explainers connected to the financials view.

Browse Health Care